These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
890 related items for PubMed ID: 13678973
1. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Jackson JB, Musoke P, Fleming T, Guay LA, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Owor M, Ducar C, Deseyve M, Mwatha A, Emel L, Duefield C, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Gigliotti M, Bray D, Mmiro F. Lancet; 2003 Sep 13; 362(9387):859-68. PubMed ID: 13678973 [Abstract] [Full Text] [Related]
2. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Ducar C, Deseyve M, Emel L, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Dransfield K, Bray D, Mmiro F, Jackson JB. Lancet; 1999 Sep 04; 354(9181):795-802. PubMed ID: 10485720 [Abstract] [Full Text] [Related]
3. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Siegfried N, van der Merwe L, Brocklehurst P, Sint TT. Cochrane Database Syst Rev; 2011 Jul 06; (7):CD003510. PubMed ID: 21735394 [Abstract] [Full Text] [Related]
4. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. Kesho Bora Study Group, de Vincenzi I. Lancet Infect Dis; 2011 Mar 06; 11(3):171-80. PubMed ID: 21237718 [Abstract] [Full Text] [Related]
5. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P. Cochrane Database Syst Rev; 2007 Jan 24; (1):CD003510. PubMed ID: 17253490 [Abstract] [Full Text] [Related]
6. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial. Wiktor SZ, Ekpini E, Karon JM, Nkengasong J, Maurice C, Severin ST, Roels TH, Kouassi MK, Lackritz EM, Coulibaly IM, Greenberg AE. Lancet; 1999 Mar 06; 353(9155):781-5. PubMed ID: 10459958 [Abstract] [Full Text] [Related]
7. Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial. Taha TE, Kumwenda NI, Gibbons A, Broadhead RL, Fiscus S, Lema V, Liomba G, Nkhoma C, Miotti PG, Hoover DR. Lancet; 2003 Oct 11; 362(9391):1171-7. PubMed ID: 14568737 [Abstract] [Full Text] [Related]
8. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial. Petra Study Team. Lancet; 2002 Apr 06; 359(9313):1178-86. PubMed ID: 11955535 [Abstract] [Full Text] [Related]
9. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial. Taha TE, Kumwenda NI, Hoover DR, Fiscus SA, Kafulafula G, Nkhoma C, Nour S, Chen S, Liomba G, Miotti PG, Broadhead RL. JAMA; 2004 Jul 14; 292(2):202-9. PubMed ID: 15249569 [Abstract] [Full Text] [Related]
10. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. Thior I, Lockman S, Smeaton LM, Shapiro RL, Wester C, Heymann SJ, Gilbert PB, Stevens L, Peter T, Kim S, van Widenfelt E, Moffat C, Ndase P, Arimi P, Kebaabetswe P, Mazonde P, Makhema J, McIntosh K, Novitsky V, Lee TH, Marlink R, Lagakos S, Essex M, Mashi Study Team. JAMA; 2006 Aug 16; 296(7):794-805. PubMed ID: 16905785 [Abstract] [Full Text] [Related]
11. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Brocklehurst P, Volmink J. Cochrane Database Syst Rev; 2002 Aug 16; (1):CD003510. PubMed ID: 11869666 [Abstract] [Full Text] [Related]
12. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Brocklehurst P, Volmink J. Cochrane Database Syst Rev; 2002 Aug 16; (2):CD003510. PubMed ID: 12076484 [Abstract] [Full Text] [Related]
13. Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials. Six Week Extended-Dose Nevirapine (SWEN) Study Team, Bedri A, Gudetta B, Isehak A, Kumbi S, Lulseged S, Mengistu Y, Bhore AV, Bhosale R, Varadhrajan V, Gupte N, Sastry J, Suryavanshi N, Tripathy S, Mmiro F, Mubiru M, Onyango C, Taylor A, Musoke P, Nakabiito C, Abashawl A, Adamu R, Antelman G, Bollinger RC, Bright P, Chaudhary MA, Coberly J, Guay L, Fowler MG, Gupta A, Hassen E, Jackson JB, Moulton LH, Nayak U, Omer SB, Propper L, Ram M, Rexroad V, Ruff AJ, Shankar A, Zwerski S. Lancet; 2008 Jul 26; 372(9635):300-13. PubMed ID: 18657709 [Abstract] [Full Text] [Related]
14. A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe. Thistle P, Spitzer RF, Glazier RH, Pilon R, Arbess G, Simor A, Boyle E, Chitsike I, Chipato T, Gottesman M, Silverman M. Clin Infect Dis; 2007 Jan 01; 44(1):111-9. PubMed ID: 17143826 [Abstract] [Full Text] [Related]
15. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Shaffer N, Chuachoowong R, Mock PA, Bhadrakom C, Siriwasin W, Young NL, Chotpitayasunondh T, Chearskul S, Roongpisuthipong A, Chinayon P, Karon J, Mastro TD, Simonds RJ. Lancet; 1999 Mar 06; 353(9155):773-80. PubMed ID: 10459957 [Abstract] [Full Text] [Related]
16. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. Moodley D, Moodley J, Coovadia H, Gray G, McIntyre J, Hofmyer J, Nikodem C, Hall D, Gigliotti M, Robinson P, Boshoff L, Sullivan JL, South African Intrapartum Nevirapine Trial (SAINT) Investigators. J Infect Dis; 2003 Mar 01; 187(5):725-35. PubMed ID: 12599045 [Abstract] [Full Text] [Related]
17. Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection. Suksomboon N, Poolsup N, Ket-Aim S. J Clin Pharm Ther; 2007 Jun 01; 32(3):293-311. PubMed ID: 17489882 [Abstract] [Full Text] [Related]
18. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission. Dabis F, Bequet L, Ekouevi DK, Viho I, Rouet F, Horo A, Sakarovitch C, Becquet R, Fassinou P, Dequae-Merchadou L, Welffens-Ekra C, Rouzioux C, Leroy V, ANRS 1201/1202 DITRAME PLUS Study Group. AIDS; 2005 Feb 18; 19(3):309-18. PubMed ID: 15718842 [Abstract] [Full Text] [Related]
19. Single-dose Nevirapine during pregnancy. Sax PE. AIDS Clin Care; 1999 Oct 18; 11(10):84-5. PubMed ID: 11366708 [Abstract] [Full Text] [Related]
20. Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine. Chung MH, Kiarie JN, Richardson BA, Lehman DA, Overbaugh J, John-Stewart GC. AIDS; 2005 Sep 02; 19(13):1415-22. PubMed ID: 16103773 [Abstract] [Full Text] [Related] Page: [Next] [New Search]